Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocugen (OCGN) EBIT (2016 - 2025)

Ocugen's EBIT history spans 12 years, with the latest figure at -$17.0 million for Q4 2025.

  • For Q4 2025, EBIT fell 22.8% year-over-year to -$17.0 million; the TTM value through Dec 2025 reached -$62.9 million, down 14.9%, while the annual FY2025 figure was -$62.9 million, 14.9% down from the prior year.
  • EBIT reached -$17.0 million in Q4 2025 per OCGN's latest filing, up from -$17.6 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of -$7.1 million in Q1 2021 to a low of -$25.6 million in Q2 2021.
  • Average EBIT over 5 years is -$16.5 million, with a median of -$15.0 million recorded in 2021.
  • Peak YoY movement for EBIT: tumbled 660.84% in 2021, then soared 50.65% in 2023.
  • A 5-year view of EBIT shows it stood at -$14.6 million in 2021, then crashed by 60.27% to -$23.4 million in 2022, then surged by 50.65% to -$11.5 million in 2023, then dropped by 20.09% to -$13.8 million in 2024, then dropped by 22.8% to -$17.0 million in 2025.
  • Per Business Quant, the three most recent readings for OCGN's EBIT are -$17.0 million (Q4 2025), -$17.6 million (Q3 2025), and -$13.8 million (Q2 2025).